Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Freeport-McMoRan (FCX) Declares $0.08 Dividend
Business

Seagen: FDA Grants Accelerated Approval For Padcev Combination To Treat Metastatic Urothelial Cancer

(RTTNews) – The U.S. Food and Drug Administration granted Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) accelerated approval in the U.S. as a combination therapy for